FULCRUM THERAPEUTICS INC. - COMMON STOCK
3.8200
04-10月-24 15:59:57
15 分の遅延
株式
+0.1550
+4.23%
本日の幅
3.6850 - 3.8400
ISIN
N/A
ソース
NASDAQ
-
27 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
20 2 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
06 2 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 12 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 11 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences
09 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
07 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
31 10 2023 08:50:33 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at the Cantor Fitzgerald Global Healthcare Conference
22 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 9 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
07 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
FDA Lifts Clinical Hold on Fulcrum Therapeutics’ FTX-6058 for Sickle Cell Disease
22 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 8 2023 16:53:28 提供 Nasdaq GlobeNewswire
-
03 8 2023 07:01:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Chief Financial Officer
03 8 2023 06:55:00 提供 Nasdaq GlobeNewswire
-
27 7 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Signs Exclusive Global License Agreement in Rare Hematology
10 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 7 2023 17:30:31 提供 Nasdaq GlobeNewswire
-
20 6 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 6 2023 16:54:20 提供 Nasdaq GlobeNewswire